Congress funds brain aneurysm research to close a deadly gap
H.R. 2678 — Ellie’s Law · Filed by Brian Fitzpatrick (R-PA) · 55 cosponsors · Introduced Apr 7, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes $20 million per year for five years (2026–2030) to the National Institute of Neurological Disorders and Stroke to conduct research on unruptured brain aneurysms, with a focus on diverse patient populations. The bill is named after five people who died from ruptured aneurysms and includes detailed biographical narratives of each victim to establish the public-health case for the research investment.
Why we flagged it
The bill's sole operative mechanism is a straightforward appropriations authorization for federally directed medical research at a named NIH institute. The biographical framing is memorial in character but does not alter the bill's functional nature as a research-funding statute.
What the text implies
- The bill's emphasis on disparate impact (higher rupture rates in African Americans and Hispanics) may drive research design toward underrepresented populations, potentially improving health equity in aneurysm outcomes.
- The $20M annual authorization is modest relative to the $2B annual direct cost burden cited in findings; actual appropriations will depend on separate budget action and may fall short of research needs.
- The five-year window (2026–2030) with funds remaining available through 2033 creates a six-year spending window, allowing flexibility but also potential for underspending if appropriations lapse.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds federally directed medical research addressing a condition affecting 6.8 million Americans with high mortality and disparate impact on women and communities of color. The research is intended to improve early detection and treatment, reducing preventable deaths and long-term disability. No restrictions on citizen rights, no liability shields, and no private carve-outs are present.
Who stands to gain
- National Institute of Neurological Disorders and Stroke (federal research institute)
- Academic medical centers and research universities conducting NIH-funded studies
- Medical device and pharmaceutical companies developing aneurysm diagnostics and treatments
Named in the bill
National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), International Study on Unruptured Intracranial Aneurysms (ISUIA), House Committee on Energy and Commerce
Where it stands
55 cosponsors: 47 Democrats, 8 Republicans.
- Apr 7, 2025 — Introduced · Congress.gov: “Introduced in House”
- Apr 7, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (5,452 characters) on Aug 17, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress funds brain aneurysm research to close a deadly gap” QuorumCivic. https://share.quorumcivic.app/bill/119/hr2678 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.